The latest financial statement is for the quarter ending 2025-12-31.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Total adjusted ebitda | 135,867 | 286,406 | - |
| Interest expense (income), net | -47,358 | -55,940 | - |
| Income tax benefit (provision) | -4,950 | -21,060 | - |
| Depreciation, amortization and product development amortization | 95,671 | 92,822 | - |
| Restructuring and cost savings implementation charges | 3,894 | 1,774 | - |
| Advisory fees | 0 | 625 | - |
| Transaction and integration costs | 548 | 170 | - |
| Stock-based compensation | 661 | 31,076 | - |
| (gain) loss on extinguishment of debt | -8,183 | -16,361 | - |
| Other | 4,701 | 3,414 | - |
| Net income (loss) | -20,199 | 105,284 | 502 |
| Depreciation (including amortization of technology costs) | 27,308 | 17,723 | 17,187 |
| Amortization of intangibles | 55,417 | 56,385 | 57,365 |
| Amortization of product development costs | 12,946 | 18,714 | 13,302 |
| Amortization of capitalized contract costs-Royalty | 9,397 | 23,588 | 34,669 |
| Amortization of capitalized contract costs-Commission Costs | 3,350 | 5,198 | 7,435 |
| Stock-based compensation | 661 | 31,076 | - |
| Credit losses on accounts receivable | -765 | 2,522 | -2,286 |
| Unrealized (gain) loss on interest rate cap | 0 | 0 | 0 |
| Inventory obsolescence | 141 | 4,673 | 3,486 |
| Deferred income taxes | -97 | 78 | 864 |
| Amortization of debt discount | 3,106 | 3,489 | 3,352 |
| Amortization of deferred financing costs | 1,210 | 1,281 | 1,253 |
| (gain) loss on extinguishment of debt | -8,183 | -16,361 | - |
| Accounts receivable | -425,003 | 219,081 | 105,289 |
| Inventories | 36,658 | -22,982 | -10,544 |
| Prepaid and other current assets | -6,280 | 70,922 | 28,185 |
| Accounts payable and accrued expenses | 14,366 | 51,935 | -91,569 |
| Deferred revenue | -217,110 | 263,627 | -27,553 |
| Other current liabilities | 11,066 | -65,422 | 12,233 |
| Other changes in operating assets and liabilities, net | -5,361 | 4,508 | 3,962 |
| Cash provided by (used for) operating activities | 308,966 | 264,983 | -96,652 |
| Product development expenditures | 27,604 | 26,288 | 22,788 |
| Capital expenditures | 23,561 | 21,195 | 16,283 |
| Cash provided by (used for) investing activities | -51,165 | -47,483 | -39,071 |
| Payment of term loan facility-AECash Flow Credit Facilities AETerm Loan Facility | 595,575 | - | - |
| Payment of term loan facility | - | 388,991 | 3,292 |
| Payment of term loan facility-Term Loan Facility | 0 | - | - |
| Borrowings on 2024 secured notes | 0 | 0 | - |
| Payment of finance lease obligations | 2,165 | 2,029 | 1,718 |
| Payment of deferred financing costs | 0 | 0 | - |
| Proceeds from issuance of common stock in initial public offering, net of underwriting discounts | 0 | 392,862 | - |
| Deferred initial public offering costs | 1,852 | 2,811 | 2,374 |
| Cash provided by (used for) financing activities | -207,309 | -969 | -7,384 |
| Effect of exchange rate changes on cash | 713 | -675 | 608 |
| Net change in cash and cash equivalents | 51,205 | 215,856 | -142,499 |
| Cash and cash equivalents at beginning of period | 463,187 | 389,830 | - |
| Cash and cash equivalents at end of period | 514,392 | 463,187 | - |
McGraw Hill, Inc. (MH)
McGraw Hill, Inc. (MH)